Medical Device | November 02, 2021
Thermo Fisher Scientific realigns product portfolio
Consolidation of the Acros Organics, Alfa Aesar and Maybridge brands to one single brand, Thermo Scientific
Consolidation of the Acros Organics, Alfa Aesar and Maybridge brands to one single brand, Thermo Scientific
It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development
The applications navigate through more than 100 workflows across biotech, pharma, healthcare, food, forensics, industrial and applied sciences industries
It approves tissue-based NGS companion diagnostic for Takeda's targeted therapy for NSCLC patients with EGFR Exon20 insertion mutations
Notably, 36 female students have been placed in Production and Manufacturing roles, reflecting the growing representation of women in core biotech operations
Shares and American Depositary Shares of Olink for $26.00 per Share
GMP certification helps enable biotechnology customers to accelerate accessibility of new RNA-based therapies for patients
Julie is recognized as a highly engaging multi-cultural leader skilled in fluidly partnering with cross-functional teams to deliver results.
A total of 889 M&A deals were announced in the medical devices sector in 2022 worth $93 billion
Cell sorting technology supports researchers advancing new therapies
Subscribe To Our Newsletter & Stay Updated
